MOHAMMED AL-HAIDER: Open Payments
NPI 1750640249 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$149 in 8 payments from 6 companies in 2025. Trend: 2023 $140 · 2024 $89 · 2025 $149
Food & beverage: $149
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Amgen Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Indivior Inc. | 1 | $18 |
Products named: AIRSUPRA, Dexcom G6 Transmitter, PAXLOVID, XIFAXAN, SUBLOCADE, REPATHA, OTEZLA.
Industry payments across TX — which companies pay providers there.
